OS-016 Week 48 top-line results from the phase 2b, multicenter, randomized, placebo-controlled IMPACT trial of pemvidutide in metabolic dysfunction-associated steatohepatitis

Journal of Hepatology 2026

View at publisher
Authors: Mazen Noureddin, Naim Alkhouri, Stephen A. Harrison, Rohit Loomba, Naga Chalasani, Shaheen Tomah, Julio Gutierrez, Dr John Suschak, M. Scot Roberts, Rachel Garner, Sarah Browne, Christophe Arbet‐Engels
+1 more M. SCOTT HARRIS
DOI: 10.1016/s0168-8278(26)00326-0
Cited by: 1

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Drug-Induced Hepatotoxicity and Protection Pancreatitis Pathology and Treatment

Publication details

Journal / source
Journal of Hepatology
Publisher
Elsevier BV
Volume
84
Pages
S19–S19
Publication date
1 May 2026
Language
EN